Ombitasvir/ABT-450 (Paritaprevir)/Ritonavir With Dasabuvir and Ribavirin (RBV) in Treatment Naive and Treatment Experienced Genotype 1a Hepatitis C Virus Infected Adults

PHASE3CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 30, 2015

Primary Completion Date

August 31, 2016

Study Completion Date

December 31, 2016

Conditions

Chronic Hepatitis CHepatitis C (HCV)Hepatitis C Genotype 1a

Interventions

DRUG

ombitasvir/paritaprevir/ritonavir

ombitasvir/ABT-450/ritonavir tablets

DRUG

dasabuvir

dasabuvir tablets

DRUG

ribavirin

ribavirin tablets